FDA Approves First Digital Pill That Can Track If You've Taken It
Abilify MyCite is a tablet with an embedded sensor activated by fluid in the stomach. Although the drug's approval is a big step for digital medicine, there are concerns about privacy and cost.
by Laurel Wamsley
Nov 14, 2017
3 minutes
The Food and Drug Administration has approved its first digital drug: a pill embedded with a sensor that transmits whether someone has taken it.
Although the approval is a big step for digital medicine, there are concerns about privacy, convenience and cost.
The tablet and embedded sensor is called Abilify MyCite. Abilify, made by Japan-based Otsuka Pharmaceutical, is the brand-name version of , an antipsychotic drug used for treating schizophrenia, bipolar disorder and as an
You’re reading a preview, subscribe to read more.
Start your free 30 days